-
On October 1, 2025, the US implemented new tariffs: 100% on branded pharmaceuticals (exempting firms building US plants), 50% on kitchen cabinets and bathroom vanities, 30% on upholstered furniture, and 25% on heavy trucks. Citing national security, the administration aims to protect domestic manufacturing but risks raising consumer costs and complicating economic policy amid inflation concerns.
-
President Trump plans to impose 100% tariffs on pharmaceuticals and continues trade tensions with China, impacting US farmers. Nike reports a slow but ongoing recovery, while critics like Ken Griffin oppose tariffs favoring large corporations. The stories highlight economic strains and political debates in the US, with implications for global trade.
-
A woman in Hemel Hempstead received a stage 3 kidney disease diagnosis via NHS app without prior consultation, highlighting issues with digital health communication. Meanwhile, advances in genomic testing are enabling earlier detection of rare diseases, exemplified by a newborn with eye cancer and a legal case over talc-related cancer risks. These stories underscore the evolving landscape of health diagnostics and communication.
-
Texas Attorney General Ken Paxton has filed a lawsuit against Johnson & Johnson and Kenvue, alleging deceptive marketing of Tylenol to pregnant women amid unproven claims linking the drug to autism. The case follows recent political statements by Trump and Kennedy suggesting a connection, which medical experts strongly dispute. The companies defend Tylenol's safety, citing scientific consensus.
-
A California jury awarded $40 million to two women who blamed Johnson & Johnson’s talc products for their ovarian cancer. The company plans to appeal, citing scientific evidence that talc is safe. This verdict follows years of legal battles over alleged asbestos contamination and health risks.